Who makes Caudal block with dexmedetomedine?

Caudal block with dexmedetomedine is developed by Kasr El Aini Hospital.

What development phase is Caudal block with dexmedetomedine in?

Caudal block with dexmedetomedine is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Caudal block with dexmedetomedine

Kasr El Aini Hospital · FDA-approved active Small molecule Quality 0/100

At a glance

Generic name	Caudal block with dexmedetomedine
Also known as	Precedex
Sponsor	Kasr El Aini Hospital
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Effects Of Adjuvants to Caudal Anesthesia on Hemodynamics Measured By Electrical Cardiometry In Children (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Caudal block with dexmedetomedine CI brief — competitive landscape report
Caudal block with dexmedetomedine updates RSS · CI watch RSS
Kasr El Aini Hospital portfolio CI